Revvity PE Ratio 2010-2025 | RVTY
Current and historical p/e ratio for Revvity (RVTY) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Revvity PE ratio as of April 29, 2025 is 19.20.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Revvity PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-04-30 | 93.43 | 46.72 | |
| 2025-03-31 | 105.72 | $2.00 | 52.86 |
| 2024-12-31 | 111.46 | $2.21 | 50.43 |
| 2024-09-30 | 127.51 | $2.07 | 61.60 |
| 2024-06-30 | 104.59 | $1.38 | 75.79 |
| 2024-03-31 | 104.66 | $1.21 | 86.50 |
| 2023-12-31 | 108.88 | $5.50 | 19.80 |
| 2023-09-30 | 110.19 | $5.95 | 18.52 |
| 2023-06-30 | 118.18 | $6.54 | 18.07 |
| 2023-03-31 | 132.51 | $7.68 | 17.25 |
| 2022-12-31 | 139.35 | $4.58 | 30.43 |
| 2022-09-30 | 119.52 | $4.90 | 24.39 |
| 2022-06-30 | 141.19 | $5.34 | 26.44 |
| 2022-03-31 | 173.13 | $6.11 | 28.33 |
| 2021-12-31 | 199.44 | $8.08 | 24.68 |
| 2021-09-30 | 171.83 | $10.05 | 17.10 |
| 2021-06-30 | 153.04 | $10.51 | 14.56 |
| 2021-03-31 | 127.08 | $9.55 | 13.31 |
| 2020-12-31 | 142.08 | $6.48 | 21.93 |
| 2020-09-30 | 124.20 | $3.68 | 33.75 |
| 2020-06-30 | 97.00 | $2.63 | 36.88 |
| 2020-03-31 | 74.38 | $2.02 | 36.82 |
| 2019-12-31 | 95.87 | $2.04 | 47.00 |
| 2019-09-30 | 84.02 | $2.10 | 40.01 |
| 2019-06-30 | 94.97 | $2.27 | 41.84 |
| 2019-03-31 | 94.92 | $2.22 | 42.76 |
| 2018-12-31 | 77.31 | $2.13 | 36.30 |
| 2018-09-30 | 95.66 | $1.12 | 85.41 |
| 2018-06-30 | 71.96 | $1.25 | 57.56 |
| 2018-03-31 | 74.33 | $2.52 | 29.50 |
| 2017-12-31 | 71.72 | $2.64 | 27.17 |
| 2017-09-30 | 67.58 | $3.60 | 18.77 |
| 2017-06-30 | 66.70 | $3.31 | 20.15 |
| 2017-03-31 | 56.76 | $2.05 | 27.69 |
| 2016-12-31 | 50.92 | $2.13 | 23.90 |
| 2016-09-30 | 54.71 | $2.15 | 25.45 |
| 2016-06-30 | 51.05 | $2.10 | 24.31 |
| 2016-03-31 | 48.10 | $1.95 | 24.67 |
| 2015-12-31 | 52.02 | $1.88 | 27.67 |
| 2015-09-30 | 44.56 | $1.54 | 28.94 |
| 2015-06-30 | 50.97 | $1.43 | 35.65 |
| 2015-03-31 | 49.45 | $1.44 | 34.34 |
| 2014-12-31 | 42.22 | $1.38 | 30.59 |
| 2014-09-30 | 42.02 | $1.68 | 25.01 |
| 2014-06-30 | 45.08 | $1.67 | 26.99 |
| 2014-03-31 | 43.29 | $1.48 | 29.25 |
| 2013-12-31 | 39.55 | $1.46 | 27.09 |
| 2013-09-30 | 36.14 | $0.75 | 48.19 |
| 2013-06-30 | 31.05 | $0.65 | 47.77 |
| 2013-03-31 | 32.07 | $0.69 | 46.48 |
| 2012-12-31 | 30.20 | $0.61 | 49.51 |
| 2012-09-30 | 27.98 | $0.00 | 0.00 |
| 2012-06-30 | 24.42 | $0.05 | 488.45 |
| 2012-03-31 | 26.11 | $0.01 | 2611.46 |
| 2011-12-31 | 18.82 | $0.01 | 1882.44 |
| 2011-09-30 | 18.01 | $3.22 | 5.59 |
| 2011-06-30 | 25.17 | $3.02 | 8.33 |
| 2011-03-31 | 24.50 | $3.26 | 7.52 |
| 2010-12-31 | 24.02 | $3.27 | 7.35 |
| 2010-09-30 | 21.46 | $1.15 | 18.66 |
| 2010-06-30 | 19.10 | $1.16 | 16.46 |
| 2010-03-31 | 22.02 | $0.85 | 25.90 |
| 2009-12-31 | 18.91 | $0.73 | 25.90 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.373B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.368B | 26.70 |
| Elevance Health (ELV) | United States | $93.458B | 12.06 |
| CVS Health (CVS) | United States | $81.990B | 12.00 |
| Cencora (COR) | United States | $56.269B | 20.42 |
| Natera (NTRA) | United States | $20.939B | 0.00 |
| DiDi Global (DIDIY) | China | $20.365B | 29.93 |
| BioMerieux (BMXMF) | France | $15.507B | 0.00 |
| ICON (ICLR) | Ireland | $12.058B | 10.95 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.881B | 0.00 |
| Solventum (SOLV) | United States | $11.461B | 10.69 |
| CochLear (CHEOY) | Australia | $11.380B | 0.00 |
| Doximity (DOCS) | United States | $10.781B | 56.07 |
| Viatris (VTRS) | United States | $9.955B | 3.15 |
| Medpace Holdings (MEDP) | United States | $8.805B | 23.39 |
| Avantor (AVTR) | United States | $8.647B | 12.56 |
| Sonic Healthcare (SKHHY) | Australia | $8.152B | 0.00 |
| HealthEquity (HQY) | United States | $7.475B | 36.77 |
| Charles River Laboratories (CRL) | United States | $5.761B | 11.36 |
| Bausch + Lomb (BLCO) | Canada | $4.848B | 22.13 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Alignment Healthcare (ALHC) | United States | $3.446B | 0.00 |
| Organon (OGN) | United States | $3.421B | 3.45 |
| GeneDx Holdings (WGS) | United States | $3.283B | 389.90 |
| Sotera Health (SHC) | United States | $3.210B | 18.54 |
| BrightSpring Health Services (BTSG) | United States | $3.069B | 31.87 |
| Surgery Partners (SGRY) | United States | $2.863B | 32.84 |
| Concentras Parent (CON) | United States | $2.815B | 14.64 |
| Progyny (PGNY) | United States | $1.967B | 43.32 |
| Premier (PINC) | United States | $1.862B | 11.92 |
| Ardent Health Partners (ARDT) | United States | $1.806B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.788B | 38.83 |
| Agilon Health (AGL) | United States | $1.569B | 0.00 |
| PACS (PACS) | United States | $1.486B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.285B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.078B | 9.04 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| CareDx (CDNA) | United States | $1.008B | 17.10 |
| Establishment Labs Holdings (ESTA) | $0.873B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.770B | 6.09 |
| Embecta (EMBC) | United States | $0.730B | 5.00 |
| Nutex Health (NUTX) | United States | $0.579B | 11.35 |
| QDM (QDMI) | Hong Kong, SAR China | $0.554B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.530B | 14.04 |
| Sonida Senior Living (SNDA) | United States | $0.444B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.402B | 37.90 |
| LifeMD (LFMD) | United States | $0.384B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.349B | 0.00 |
| SBC Medicals (SBC) | United States | $0.347B | 0.00 |
| DocGo (DCGO) | United States | $0.233B | 9.50 |
| Oncology Institute (TOI) | United States | $0.189B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.184B | 0.00 |
| Beauty Health (SKIN) | United States | $0.125B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.112B | 0.00 |
| OncoCyte (OCX) | United States | $0.089B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.084B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Biodesix (BDSX) | United States | $0.078B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.077B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.057B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.021B | 0.00 |
| ModivCare (MODV) | United States | $0.018B | 6.32 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| KindlyMD (KDLY) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |